Preparation and in vitro/in vivo evaluation of uniform-sized Goserelin-loaded sustained release microspheres.

Autor: Qin Y; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China; University of the Chinese Academy of Sciences, Beijing 100049, PR China., Wei Y; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China., Gao Z; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China; University of the Chinese Academy of Sciences, Beijing 100049, PR China., Liu J; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China., Sui D; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China., Hu Y; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China., Gong F; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China; University of the Chinese Academy of Sciences, Beijing 100049, PR China., Ma G; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China; Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, PR China; University of the Chinese Academy of Sciences, Beijing 100049, PR China. Electronic address: ghma@ipe.ac.cn.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov; Vol. 375, pp. 745-757. Date of Electronic Publication: 2024 Oct 01.

Efficacy and uterine bleeding patterns in initiating goserelin therapy during different menstrual phases in patients with adenomyosis: a prospective cohort study.

Autor: Lin Y; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Sun H; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Ming Y; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Wang X; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Jiao X; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Pan Z; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Ren Q; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Yan S; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Li D; Qilu Hospital of Shandong University, Jinan, China., Wang G; Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, China.; Jinan Key Laboratory of Diagnosis and Treatment of Major Gynecological Disease, Jinan, China.; Gynecology Laboratory, Shandong Provincial Hospital, Jinan, China.; Gynecology Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Publikováno v: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2024 Dec; Vol. 40 (1), pp. 2409918. Date of Electronic Publication: 2024 Oct 07.

Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.

Autor: Honma Y; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Monden N; Department of Head and Neck, Surgery, National Hospital Organization Shikoku Cancer Center, Ehime, Japan., Yamazaki K; Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medical, and Dental Sciences, Niigata University, Niigata, Japan., Kano S; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan., Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Osaka & Department of Medical Oncology, Kochi Medical School, Kochi, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan., Utsumi Y; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan., Nakatogawa T; Janssen Pharmaceutical K.K., Tokyo, Japan., Takano R; Janssen Pharmaceutical K.K., Tokyo, Japan., Fujii K; Janssen Pharmaceutical K.K., Tokyo, Japan., Koroki Y; Janssen Pharmaceutical K.K., Tokyo, Japan., Aoyama J; Janssen Pharmaceutical K.K., Tokyo, Japan., Ouchi S; Janssen Pharmaceutical K.K., Tokyo, Japan., Ogawa T; Janssen Pharmaceutical K.K., Tokyo, Japan., McCarthy S; Janssen Research & Development, Spring House, Pennsylvania, USA., Brookman-May SD; Janssen Research & Development, Spring House, Pennsylvania, USA.; Ludwig-Maximilians University (LMU), Munich, Germany., Mundle S; Janssen Research & Development, Spring House, Pennsylvania, USA., Li J; Janssen Research & Development, Spring House, Pennsylvania, USA., Thaper D; Janssen Research & Development, Spring House, Pennsylvania, USA., Nagao T; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan., Tada Y; Department of Head and Neck Oncology and Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3416-3427.

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

Autor: Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China., Wang Z; Department of Urology, Jiangsu Province Hospital, Nanjing 210029, China., Chen M; Department of Urology, Zhongda Hospital Southeast University, Nanjing 210009, China., Ma Q; Translational Research Laboratory for Urology, Ningbo First Hospital, Ningbo 315016, China., He Y; Department of Urology, First Affiliated Hospital of Jiaxing, Jiaxing 314050, China., Wang Y; Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830091, China., Li X; Department of Urology, Baotou Cancer Hospital, Baotou 014016, China., Qiu M; Department of Urology, The People's Hospital of Sichuan Province, Chengdu 610032, China., Shi L; Department of Urology, Yantai Yuhuangding Hospital, Yantai 264008, China., Zhu S; Department of Urology, Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou 310022, China., Xie Q; Department of Urology, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China., Liu X; Department of Urology, Tongji Hospital, Tongji Medical College, HUST, Wuhan 430032, China., Shi B; Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, China., Lin G; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China., Yang W; Department of Urology, Huizhou Third People's Hospital, Huizhou 516002, China., Liao Y; Department of Urology, Jiangmen Central Hospital, Jiangmen 529030, China., Zhang H; Department of Urology, Foshan First People's Hospital, Foshan 528041, China., Wang S; Department of Urology, Guangzhou Province Traditional Chinese Medical Hospital, Guangzhou 510120, China., Li J; Department of Urology, Guangzhou Panyu Central Hospital, Guangzhou 511489, China., Wang S; Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430064, China., Dong L; Department of Urology, Hebei Petro China Central Hospital (China National Petroleum Corporation Central Hospital), Langfang 065099, China., Chen H; Department of Urology, Harbin Medical University Cancer Hospital, Harbin 150086, China., Lu J; Department of Urology, Shandong Provincial Hospital, Jinan 250014, China., Cheng Y; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an 710021, China., Zhang X; Department of Urology, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430032, China., Ma L; Department of Urology, Peking University Third Hospital, Beijing 100191, China., Zhou L; Department of Urology, Peking University First Hospital, Beijing 100034, China., Wang H; Department of Urology, Tangdu Hospital, Xi'an 710024, China., Li S; Department of Urology, Shijiazhuang City First Hospital, Shijiazhuang 050012, China., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Publikováno v: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).

Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

Autor: Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China., Tong Z; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Liu Q; Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Li W; The First Bethune Hospital of Jilin University, Changchun, China., Cai L; Harbin Medical University Cancer Hospital, Harbin, China., Shen K; RuiJin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China., Li H; Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China., Wang C; Affiliated Union Hospital of Fujian Medical University, Fuzhou, China., Yang J; The 1st Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China., Song Z; Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Wang S; Jiang Su Province RenMin Hospital, Nanjing, China., Luo T; West China Hospital, Sichuan University, Chengdu, China., Zhao W; Sir Run Run Shaw Hospital/Zhejing University School of Medicine, Hangzhou, China., Wang H; The Affiliated Hospital of Qingdao University, Qingdao, China., Pan Y; Anhui Provincial Hospital, Hefei, China., Nie J; Yunnan Provincial Cancer Hospital, Kunming, China., Zeng X; Chongqing Cancer Hospital, Chongqing, China., Bai Y; Novartis Global Drug Development, Beijing, China., Chiang W; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Guarnaccia V; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Bi Y; Novartis Global Drug Development, Beijing, China., Xu B; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Publikováno v: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (15), pp. e7408.